Form 8-K - Current report:
SEC Accession No. 0001384101-23-000011
Filing Date
2023-02-22
Accepted
2023-02-22 16:08:44
Documents
14
Period of Report
2023-02-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vcyt-20230222.htm   iXBRL 8-K 37855
2 EX-99.1 vcyt-0222238xkearningsrele.htm EX-99.1 295810
6 GRAPHIC vcytlogoa.gif GRAPHIC 5822
  Complete submission text file 0001384101-23-000011.txt   504843

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vcyt-20230222.xsd EX-101.SCH 1915
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vcyt-20230222_lab.xml EX-101.LAB 25154
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vcyt-20230222_pre.xml EX-101.PRE 13058
8 EXTRACTED XBRL INSTANCE DOCUMENT vcyt-20230222_htm.xml XML 11957
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Filer) CIK: 0001384101 (see all company filings)

EIN.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36156 | Film No.: 23653165
SIC: 8071 Services-Medical Laboratories